Wermke, M., Jaeger, D., Dr., A. B. P., Chatterjee, M., Groepper, S., Heudobler, D., Hecker, J. S., Spoerl, S., Sebastian, M., Kleemiss, M., Becker, H., Knop, S., Bozorgmehr, F., Haenel, M., Missel, S., Reinhardt, C., Veremchuk, O., Ruh, M., Britten, C. M., Ochsenreither, S. (2026). First-in-human results with IMA401, a MAGEA4/8-targeted T-cell receptor–based bispecific T-cell engager (TCER) in recurrent or refractory solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2507